Προωθημένο
9 Groundbreaking Obesity Drugs Poised for Market by 2030
The global battle against obesity is gaining momentum, with multiple innovative therapies advancing through late-stage development. As attention grows around pharma news today obesity drugs, the next decade is expected to bring highly effective multi-agonist and oral treatments to patients. Among these, Eli Lilly’s retatrutide continues to capture interest, driving discussions about the...
0 Σχόλια 0 Μοιράστηκε 59 Views 0 Προεπισκόπηση
Προωθημένο
Προωθημένο
Προωθημένο